These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6697360)

  • 21. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High density lipoproteins (methods of analysis and role in human atherosclerosis).
    Avogaro P; Cazzolato G; Bittolo-Bon G; Belussi F
    Ric Clin Lab; 1982; 12(1):87-95. PubMed ID: 6806889
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of a lipid-lowering diet on lipids, lipoproteins and apolipoproteins in the serum].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1982 Sep; 33(38):1302-5. PubMed ID: 7132690
    [No Abstract]   [Full Text] [Related]  

  • 24. [Genetics and dyslipidemias].
    Brousseau T; Fruchart JCh
    Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1116-20. PubMed ID: 14694789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin cholesterol and skin apoprotein B in atherosclerosis.
    Bouissou H; de Graeve J; Legendre C; Solera ML; Wulfert E; Thiers JC
    Biomed Pharmacother; 1982; 36(3):159-62. PubMed ID: 7150710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetics of the hyperlipidemias and coronary artery disease.
    Berg K
    Prog Clin Biol Res; 1982; 103 Pt B():111-25. PubMed ID: 7163216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic basis of atherosclerosis: part I: new genes and pathways.
    Lusis AJ; Fogelman AM; Fonarow GC
    Circulation; 2004 Sep; 110(13):1868-73. PubMed ID: 15451808
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of young persons threatened with arteriosclerosis by mathematical evaluation of familial-hereditary factors].
    Khalfen ESh; Ikonnikova EI; Gorlin AI
    Ter Arkh; 1973; 45(6):60-5. PubMed ID: 4585376
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
    Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
    Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confirmation and high resolution mapping of an atherosclerosis susceptibility gene in mice on Chromosome 1.
    Phelan SA; Beier DR; Higgins DC; Paigen B
    Mamm Genome; 2002 Oct; 13(10):548-53. PubMed ID: 12420131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis.
    Dichek HL; Qian K; Agrawal N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1696-702. PubMed ID: 15205216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial penetrance of familial hyperlipoproteinemias].
    Cisárik F; Gavalec M; Hrbánová Z
    Vnitr Lek; 1980; 26(5):457-61. PubMed ID: 7395119
    [No Abstract]   [Full Text] [Related]  

  • 33. [The pathogenetic problems of atherosclerosis: the regional aspects].
    Oteva EA; Maslennikov AB; Nikolaeva AA
    Ter Arkh; 1997; 69(1):20-2. PubMed ID: 9163042
    [No Abstract]   [Full Text] [Related]  

  • 34. Apolipoprotein B in normolipemic and hyperlipoproteinaemic subjects from the city of Bombay.
    Nerurkar SV; Iyyer IR; Taskar SP
    J Postgrad Med; 1982 Jan; 28(1):13-7. PubMed ID: 7108813
    [No Abstract]   [Full Text] [Related]  

  • 35. Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease.
    Tabibiazar R; Wagner RA; Spin JM; Ashley EA; Narasimhan B; Rubin EM; Efron B; Tsao PS; Tibshirani R; Quertermous T
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):302-8. PubMed ID: 15550693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1981 Oct; 32(43):1611-5. PubMed ID: 7300661
    [No Abstract]   [Full Text] [Related]  

  • 37. [Interrelation of genetic dimorphism of ear wax and the level of apolipoproteins with atherogenesis and longevity in the Lithuanian population].
    Spitsyn VA; Stakishaĭtis DV
    Genetika; 1993 Feb; 29(2):334-41. PubMed ID: 8486262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physicochemical methods for diagnosing hyperlipoproteinemias, by determining the concentrations of apolipoproteins and protein vectors (lecture 3)].
    Titov VN; Ameliushkina BA; Rozhkova TA; Kotkina TI
    Klin Lab Diagn; 2008 May; (5):21-36. PubMed ID: 18592643
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular biology and biochemical study of hyperlipemia and atherosclerosis].
    Chen B
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):579-80. PubMed ID: 8697068
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
    Pac-Kozuchowska E
    Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.